text_1: FDA approves new drug that prevents migraines without side effects
text_2: This NBC News story takes a look at a newly approved migraine drug. We liked how the story included the cost of the drug, and discussed the lack of effective options for many patients. But the story could leave readers thinking the drug works better than it really does, because it only quotes the drug company’s rosy summary, and not what the FDA reported. Millions of Americans suffer from migraine attacks that greatly diminish their quality of life. There is currently no preventive medication with no side effects approved for patients who suffer from chronic or episodic migraines. This new drug has been hyped by Novartis’ and Amgen’s PR machines since clinical trials for them first began. It is important that people with migraines and their family members and friends (who often forward on anything and everything written about products that claim to reduce migraine attacks) are given accurate information about who a new drug is for and the extent to which it can actually improve people’s lives.